MyUltimateBiz Work from Home

Posts Tagged ‘Novartis’

New Data at ASCO Show Novartis Drug Tasigna® Surpasses Gleevec® for Newly Diagnosed CML Patients
Novartis announced today 18-month results showing that Tasigna® capsules significantly surpass the efficacy of Gleevec® tablets* in adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase.

Read more on PR Newswire via Yahoo! Finance

Related Blogs

• Hanes® and JetBlue Airways Take Comfort to New Heights – Yahoo …
• The Lowdown on Leukemia | Mesothelioma Incidence
• New therapy mounts double-barreled attack on leukemia, report UF …
• Combination Therapy Can Treat Chronic Myelogenous Leukemia (CML …
• Yahoo! Finance – Programming Blog

New Data at ASCO Show Novartis Drug Tasigna® Surpasses Gleevec® for Newly Diagnosed CML Patients
Novartis announced today 18-month results showing that Tasigna® capsules significantly surpass the efficacy of Gleevec® tablets* in adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase.

Read more on PR Newswire via Yahoo! Finance

Related Blogs

• Epstein–Barr virus involvement in the pathogenesis of hydroa …
• The Science and Technology Blog » Blog Archive » Second-line CML …
• CytRx Initiates Phase 2 Clinical Trial With Bafetinib In B-cell …
• Valuecruncher » Blog Archive » Why hasn't Yahoo Finance changed in …
• Prechter on Yahoo! Finance: "Even $1 Trillion Can't Save the Euro …

Data At ASCO Show Promise Of Novartis Drugs For Patients With Life-Threatening Diseases Like CML, Multiple Myeloma And …
Novartis Pharmaceuticals Corporation (NPC), a US subsidiary of Novartis AG, announced that nearly 170 abstracts highlighting investigational uses of current therapies and investigational agents in the Novartis Oncology portfolio will be presented at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) from June 4 through June 8 in Chicago, IL (1)…

Read more on Medical News Today

Related Blogs

• Cancer Protection is About Making Smart Decisions | vitamin d …
• Lady Gaga may have life-threatening disease | Latest News
• Abbott to present data on 4 investigational oncology compounds at …
• ASCO 2010 Multiple Myeloma Update – Day One – The Myeloma Beacon
• The Science and Technology Blog » Blog Archive » Second-line CML …

Novartis to pay millions for sex discrimination
The Basel-based pharmaceutical company Novartis has been fined $250 million (SFr289 million) in punitive damages after a New York jury found it guilty of practicing sex discrimination.

Read more on Swissinfo